Enriched leukocytes were obtained from the New York Blood Center (Long Island City, NY) after informed consent of donors who were deemed healthy by the New York Blood Center’s criteria and used under a protocol approved by the Institutional Review Board of the Hospital for Special Surgery and the Institutional Biosafety Committee of Weill Cornell Medicine (2014–221). PBMCs were prepared using Ficoll-Paque density gradient (GE Healthcare) as previously described (78 ). pDCs and monocytes were isolated from PBMCs by positive selection using BDCA4-conjugated (78 ) and CD14-conjugated (79 (link)) microbeads (Miltenyi Biotec), respectively. pDC-depleted PBMCs were prepared by removing BDCA4-positve cells from PBMCs using microbeads (Miltenyi Biotec). Macrophages were differentiated from monocytes by culturing in complete RPMI 1640 medium with macrophage colony-stimulating factor (M-CSF; 20 ng/ml) for 1 to 5 days. Vero E6 cells [African green monkey (Chlorocebus aethiops) kidney] were obtained from the American Type Culture Collection (ATCC). A549 cells (human adenocarcinomic alveolar basal epithelial) were obtained from ATCC. A549-ACE2 cells were obtained from B.R.t. (Mount Sinai).
Bdca4 conjugated 78
Manufactured by Miltenyi Biotec
The BDCA4-conjugated (78) is a laboratory instrument designed for the detection and analysis of specific cell types in biological samples. It is a highly specific antibody that binds to the BDCA4 surface marker, allowing for the identification and quantification of plasmacytoid dendritic cells (pDCs) within a sample. The core function of this product is to facilitate the accurate identification and characterization of pDCs, which play a crucial role in immune system regulation and function.
Automatically generated - may contain errors
2 protocols using bdca4 conjugated 78
1
Isolation of Immune Cells for COVID-19 Research
2
Isolation of Immune Cells for COVID-19 Research
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Enriched leukocytes were obtained from the New York Blood Center (Long Island City, NY) after informed consent of donors who were deemed healthy by the New York Blood Center’s criteria and used under a protocol approved by the Institutional Review Board of the Hospital for Special Surgery and the Institutional Biosafety Committee of Weill Cornell Medicine (2014–221). PBMCs were prepared using Ficoll-Paque density gradient (GE Healthcare) as previously described (78 ). pDCs and monocytes were isolated from PBMCs by positive selection using BDCA4-conjugated (78 ) and CD14-conjugated (79 (link)) microbeads (Miltenyi Biotec), respectively. pDC-depleted PBMCs were prepared by removing BDCA4-positve cells from PBMCs using microbeads (Miltenyi Biotec). Macrophages were differentiated from monocytes by culturing in complete RPMI 1640 medium with macrophage colony-stimulating factor (M-CSF; 20 ng/ml) for 1 to 5 days. Vero E6 cells [African green monkey (Chlorocebus aethiops) kidney] were obtained from the American Type Culture Collection (ATCC). A549 cells (human adenocarcinomic alveolar basal epithelial) were obtained from ATCC. A549-ACE2 cells were obtained from B.R.t. (Mount Sinai).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!